BATS BZX Real-Time Price
As of 1:04pm ET
| +0.32 / +0.80%|
The 10 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 43.00, with a high estimate of 50.00 and a low estimate of 38.00. The median estimate represents a +6.07% increase from the last price of 40.54.
The current consensus among 9 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.